Most babies receive their first vaccine that protects against meningitis at 2 months old. But there isn’t a single “meningitis vaccine.” Several different vaccines protect against the different bacteria that cause meningitis in young children, and they follow slightly different schedules. Understanding which vaccines cover what, and when your baby needs each one, helps you stay on track with protection during the most vulnerable years.
Three Vaccines That Protect Against Meningitis
Meningitis is an infection of the lining around the brain and spinal cord, and several types of bacteria can cause it. In the U.S., three childhood vaccines target the most common bacterial culprits:
- Hib vaccine protects against Haemophilus influenzae type b, which was the leading cause of bacterial meningitis in children under 5 before the vaccine became routine. It can also lead to brain damage and deafness.
- Pneumococcal vaccine (PCV) protects against pneumococcal bacteria, which cause meningitis along with pneumonia and ear infections.
- Meningococcal vaccine (MenACWY) protects against four strains of meningococcal bacteria (serogroups A, C, W, and Y). This one is only given routinely to preteens and teens, not to all babies.
A fourth type, the serogroup B meningococcal vaccine (MenB), is approved for ages 10 and older and is primarily recommended for teenagers and young adults through shared decision-making with a healthcare provider.
The Hib Vaccine Schedule
The Hib vaccine is the earliest and most direct defense against bacterial meningitis for infants. It’s given as a 3- or 4-dose series depending on the brand, starting at 2 months. The typical schedule is doses at 2 months, 4 months, and 6 months, with a final booster between 12 and 15 months. Some brands skip the 6-month dose and complete the series with just three shots.
Before this vaccine existed, Hib was responsible for roughly 20,000 serious infections per year in U.S. children under 5. The vaccine has nearly eliminated Hib meningitis in countries where it’s used routinely.
The Pneumococcal Vaccine Schedule
The pneumococcal conjugate vaccine (PCV15 or PCV20) follows a 4-dose series for all children under 5. Doses are given at 2 months, 4 months, 6 months, and between 12 and 15 months. This schedule closely mirrors the Hib vaccine, so your baby will often receive both at the same visit.
Pneumococcal bacteria cause a range of infections beyond meningitis, including pneumonia and ear infections. The vaccine covers the strains most likely to cause serious, invasive disease in young children.
When Babies Need the Meningococcal Vaccine
This is where the schedule differs from what many parents expect. The meningococcal conjugate vaccine (MenACWY) is not part of the routine infant schedule. For healthy children with no special risk factors, the first dose is recommended at age 11 or 12, with a booster at 16.
However, babies as young as 6 weeks can receive certain MenACWY vaccines if they have specific risk factors. One approved brand can be given as a 4-dose series at 2, 4, 6, and 12 to 18 months for high-risk infants. The conditions that qualify a baby for early meningococcal vaccination include:
- Functional or anatomic asplenia: a missing or non-functioning spleen
- HIV infection
- Complement deficiencies: problems with a part of the immune system that helps fight bacteria
- Travel to regions where meningococcal disease is common
- Exposure during an outbreak
If your child doesn’t fall into any of these categories, the meningococcal vaccine will wait until the preteen years. The Hib and pneumococcal vaccines provide the primary meningitis protection during infancy.
Why Vaccines Start at 2 Months
Newborns arrive with some borrowed immunity. During pregnancy, the mother’s antibodies cross the placenta, with most of the transfer happening during the third trimester. These antibodies give infants a window of protection during their first weeks of life, but they fade. Studies show maternal antibodies against meningococcal bacteria typically last only 2 to 5 months after birth, often becoming undetectable after about 80 days.
The 2-month starting point is designed to begin building the baby’s own immune response just as that borrowed protection wanes. Before 6 to 8 weeks, an infant’s immune system generally responds poorly to vaccines, so starting earlier wouldn’t offer much benefit. The multi-dose schedule, with shots spaced 2 months apart, gradually builds stronger and longer-lasting immunity with each dose. The final booster around 12 to 15 months reinforces protection as the child becomes more mobile and socially exposed.
What If Your Baby Misses a Dose
A missed dose doesn’t mean you need to restart the series from scratch. The CDC is clear on this: a vaccine series never needs to be restarted, regardless of how much time has passed between doses. Your pediatrician will simply pick up where you left off and adjust the timing of remaining doses.
For the Hib vaccine specifically, the catch-up rules depend on how old the child was when they received their first dose. If the first dose happened at 15 months or older, no additional doses are needed. For children who started on time but missed a middle dose, the minimum interval between catch-up doses is typically 4 to 8 weeks, depending on the child’s current age and how many doses they’ve already received.
Common Side Effects in Babies
Side effects from these vaccines are generally mild and short-lived. Soreness, redness, or swelling at the injection site are the most common reactions. Low-grade fever, fussiness, and fatigue can also occur. These symptoms typically appear within a day or two of vaccination and resolve on their own within 2 to 3 days.
The meningococcal B vaccine, given to older children and teens rather than infants, tends to cause more noticeable side effects. Soreness, fatigue, headache, muscle pain, fever, and nausea occur in more than half of recipients. The infant vaccines (Hib and PCV) are generally better tolerated.
Recent Changes to the Schedule
In April 2025, a new pentavalent meningococcal vaccine (MenABCWY) was approved for use when both the MenACWY and MenB vaccines are needed at the same visit. This combined vaccine is for people 10 and older, so it doesn’t change the infant schedule. It simplifies things for teenagers and high-risk individuals who previously needed separate shots for different meningococcal strains. The core infant schedule for Hib and pneumococcal vaccines remains unchanged for 2025.